Randomized Assessment of Safety and Immunogenicity of Intradermal Unadjuvanted Portion of Pandemrix Via a Microneedle Device With Intramuscular Adjuvanted Pandemrix as Reference.

Trial Profile

Randomized Assessment of Safety and Immunogenicity of Intradermal Unadjuvanted Portion of Pandemrix Via a Microneedle Device With Intramuscular Adjuvanted Pandemrix as Reference.

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary) ; AS03A
  • Indications Influenza A virus H1N1 subtype
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 08 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top